Beijing Youan Hospital, Capital Medical University

Beijing, Beijing Municipality 100069

2 studies enrolling now · 6 studies all time

What they study most

Advanced Hepatocellular Carcinoma, GastroIntestinal Bleeding, Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Wilson's Disease

Studies at this site

• Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding — Recruiting now
• Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients. — Starting soon
• A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma — Running, not enrolling
• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed
• YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC) — Completed
• Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) — Completed